Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution Multi-Sector ETF (ARKG)

Ark Genomic Revolution Multi-Sector ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 1,360,905,800
  • Market Capitalization, $K 1,360,906
  • Shares Outstanding, K 25,605
  • 60-Month Beta 1.68
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 2.11 (3.90%)
  • Most Recent Dividend 2.108 on 12/27/19
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.19 +28.12%
on 06/12/20
54.75 -1.26%
on 07/02/20
+5.95 (+12.37%)
since 06/02/20
3-Month
29.54 +83.01%
on 04/03/20
54.75 -1.26%
on 07/02/20
+23.98 (+79.69%)
since 04/02/20
52-Week
24.00 +125.25%
on 03/18/20
54.75 -1.26%
on 07/02/20
+20.01 (+58.77%)
since 07/02/19

Most Recent Stories

More News
Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

JNJ : 140.97 (+0.42%)
AZN : 53.80 (+0.90%)
PFE : 34.51 (+2.28%)
MRNA : 58.57 (-4.90%)
IBB : 138.54 (+0.85%)
XBI : 112.89 (+0.37%)
BBH : 165.81 (+0.69%)
FBT : 170.54 (+0.48%)
ARKG : 54.06 (+1.64%)
4 Sector ETFs Up More Than 30% in First-Half 2020

We have highlighted four ETFs from various industries that were the star performers in the first half and are likely to continue their outperformance if the current trends continue.

MSFT : 206.26 (+0.76%)
AMZN : 2,890.30 (+0.40%)
AAPL : 364.11 (unch)
FB : 233.42 (-1.74%)
ARKG : 54.06 (+1.64%)
ONLN : 54.22 (+1.88%)
WCLD : 40.33 (+0.22%)
FNGS : 75.27 (+1.43%)
Top & Flop Zones of First-Half 2020 and Their ETFs

Inside the best and worst performing ETFs of first half.

USO : 28.75 (+1.41%)
VXX : 32.32 (-1.73%)
JETS : 16.59 (+0.42%)
ARKG : 54.06 (+1.64%)
BDRY : 8.05 (+11.81%)
WCLD : 40.33 (+0.22%)
New GERM ETF Launched to Tap the Growing Biotech Sector

GERM invests in the hottest emerging biotechnology trends.

MRNA : 58.57 (-4.90%)
ALNY : 149.87 (+0.74%)
BIO : 458.36 (+0.86%)
SBIO : 42.15 (unch)
PBE : 59.49 (+1.09%)
ARKG : 54.06 (+1.64%)
How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

GILD : 76.35 (+0.38%)
LLY : 163.87 (+0.35%)
IBB : 138.54 (+0.85%)
XBI : 112.89 (+0.37%)
BBH : 165.81 (+0.69%)
FBT : 170.54 (+0.48%)
ARKG : 54.06 (+1.64%)
5 ETFs Up More Than 20% in Three Months

Wall Street has been performing impressively with the major indices climbing to a 12-week high. The rally was mainly powered by optimism over a potential coronavirus vaccine as well as an uptick in the...

SGDM : 31.08 (-1.18%)
IBUY : 73.35 (+1.58%)
ARKG : 54.06 (+1.64%)
WCLD : 40.33 (+0.22%)
URNM : 27.35 (+0.74%)
Biotech ETFs Soaring on COVID-19 Vaccine Progress

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

JNJ : 140.97 (+0.42%)
AZN : 53.80 (+0.90%)
MRNA : 58.57 (-4.90%)
NVAX : 81.64 (+2.43%)
IBB : 138.54 (+0.85%)
XBI : 112.89 (+0.37%)
BBH : 165.81 (+0.69%)
FBT : 170.54 (+0.48%)
ARKG : 54.06 (+1.64%)
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine. This new opportunity has made the sector the most attractive one to investors.

JNJ : 140.97 (+0.42%)
SNY : 51.62 (+0.68%)
PFE : 34.51 (+2.28%)
MRK : 78.78 (+0.84%)
MRNA : 58.57 (-4.90%)
GSK : 41.22 (+0.88%)
NVAX : 81.64 (+2.43%)
IBB : 138.54 (+0.85%)
XBI : 112.89 (+0.37%)
BBH : 165.81 (+0.69%)
BBC : 43.23 (-0.41%)
ARKG : 54.06 (+1.64%)
BNTX : 63.27 (-1.36%)
GNOM : 18.15 (+1.06%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 53.80 (+0.90%)
MRNA : 58.57 (-4.90%)
GSK : 41.22 (+0.88%)
NVAX : 81.64 (+2.43%)
CNCR : 27.20 (+0.79%)
INO : 21.45 (+8.72%)
PTH : 122.47 (+0.71%)
BBC : 43.23 (-0.41%)
BTEC : 44.85 (+0.26%)
ARKG : 54.06 (+1.64%)
IDN : 7.54 (+4.58%)
VXRT : 7.37 (-7.88%)
GNOM : 18.15 (+1.06%)
Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

GSK : 41.22 (+0.88%)
PBE : 59.49 (+1.09%)
ARKG : 54.06 (+1.64%)
GNOM : 18.15 (+1.06%)
IDNA : 38.03 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ARKG with:

Fund Summary

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology,...

See More

Top 10 Holdings

Name % Holdings
CRISPR Therapeutics AG 9.33%
Invitae Corp 8.54%
ILLUMINA INC 8.31%
Compugen Ltd 7.32%
ARCTURUS THERAPEUTICS HOLDIN 6.38%
Intellia Therapeutics Inc 5.13%
Iovance Biotherapeutics Inc 4.08%
EDITAS MEDICIN 3.66%
CareDx Inc 3.54%
CELLECTIS - ADR 3.33%

See More

Key Turning Points

2nd Resistance Point 55.43
1st Resistance Point 54.75
Last Price 54.06
1st Support Level 53.38
2nd Support Level 52.69

See More

52-Week High 54.75
Last Price 54.06
Fibonacci 61.8% 43.00
Fibonacci 50% 39.38
Fibonacci 38.2% 35.75
52-Week Low 24.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar